Lexicon Pharmaceuticals's market cap is currently $275.75M. The company's EPS TTM is $-0.745; its P/E ratio is ―; Lexicon Pharmaceuticals is scheduled to report earnings on March 12, 2025, and the estimated EPS forecast is $-0.13. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 1.20M	$ 139.00K	$ 298.00K	$ 24.00M	$ 322.07M
Gross Profit	$ 1.12M	$ -288.00K	$ -54.75M	$ 22.07M	$ 318.84M
Operating Income	$ -171.75M	$ -100.76M	$ -87.09M	$ -178.78M	$ 141.44M
EBITDA	$ -163.46M	$ -98.74M	$ -86.66M	$ -41.10M	$ 173.74M
Net Income	$ -177.12M	$ -103.13M	$ -88.27M	$ -70.18M	$ 130.13M
Balance Sheet
Cash & Short-Term Investments	$ 170.03M	$ 138.36M	$ 86.74M	$ 152.28M	$ 271.66M
Total Assets	$ 229.43M	$ 194.30M	$ 136.91M	$ 203.79M	$ 417.71M
Total Debt	$ 106.06M	$ 55.29M	$ 2.28M	$ 12.81M	$ 246.28M
Net Debt	$ 83.60M	$ 8.95M	$ -61.79M	$ -113.45M	$ 210.17M
Total Liabilities	$ 136.32M	$ 77.17M	$ 23.31M	$ 47.42M	$ 300.61M
Stockholders' Equity	$ 93.11M	$ -1.59B	$ -1.49B	$ 156.37M	$ -1.34B
Cash Flow
Free Cash Flow	$ -162.37M	$ -90.18M	$ -88.24M	$ -143.06M	$ 113.74M
Operating Cash Flow	$ -161.90M	$ -88.85M	$ -87.02M	$ -142.97M	$ 113.81M
Investing Cash Flow	$ -49.94M	$ -71.08M	$ 2.11M	$ 380.76M	$ -155.85M
Financing Cash Flow	$ 187.96M	$ 142.21M	$ 22.71M	$ -147.64M	$ -2.23M

Currency in USD

Lexicon Pharmaceuticals Earnings and Revenue History

Income Statement >

Lexicon Pharmaceuticals Debt to Assets

Balance Sheet >

Lexicon Pharmaceuticals Cash Flow

Cash Flow >

Lexicon Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing